title: Delayed oral toxicity from long-term vemurafenib therapy.
authors: Department of Dermatology, Churchill Hospital, Oxford University Hospitals NHS Trust, Old Road, Oxford, OX3 7LE, U.K.. alloydlavery@gmail.com.
authors: A
authors: A
authors: Lloyd-Lavery
authors: Department of Oral Medicine, Eastman Dental Hospital, University College London Hospitals NHS Foundation Trust, London, U.K.
authors: T
authors: T
authors: Hodgson
authors: Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Trust, Old Road, Oxford, OX3 7LE, U.K.
authors: N
authors: N
authors: Coupe
authors: Department of Oral Surgery, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, U.K.
authors: S
authors: S
authors: Bond
authors: Department of Histopathology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, U.K.
authors: K
authors: K
authors: Shah
authors: Department of Histopathology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, U.K.
authors: O
authors: O
authors: Espinosa
authors: Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Trust, Old Road, Oxford, OX3 7LE, U.K.
authors: M J
authors: MJ
authors: Payne
authors: Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Trust, Old Road, Oxford, OX3 7LE, U.K.
authors: M R
authors: MR
authors: Middleton
authors: Department of Dermatology, Churchill Hospital, Oxford University Hospitals NHS Trust, Old Road, Oxford, OX3 7LE, U.K.
authors: R N
authors: RN
authors: Matin
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005885:Gingival Hyperplasia / Q000139:chemically induced; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D009059:Mouth Diseases / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013280:Stomatitis / Q000139:chemically induced; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib